The composition of the gut microbiome has been shown to influence disease outcome in patients with colorectal cancer (CRC). In a recent Nature Biotechnology article, Wang et al. demonstrate that killing CRC-associated bacteria with a liposomal antibiotic elicits CRC-targeting immune responses of therapeutic relevance as a consequence of epitope mimicry.

中文翻译：

---

细菌抗原释放肿瘤靶向免疫力

肠道微生物组的组成已被证明会影响结直肠癌 (CRC) 患者的疾病结果。在最近的《自然生物技术》文章中，Wang 等人。证明用脂质体抗生素杀死结直肠癌相关细菌，会由于表位拟态而引发具有治疗相关性的针对结直肠癌的免疫反应。